Figure 1. Concentration-response curves to cromakalim (10-7to 3 x 10 (-5) M) and pinacidil (10-7to 3 x 10-5M) in the absence and the presence of glibenclamide (5 x 10-6M), obtained in rat thoracic aortas without endothelia. Data are shown as the mean +/− SD and expressed as percent of maximal relaxation induced by papaverine (3 x 10-4M; 100%= 753 +/− 169 mg [n = 6] and 887 +/− 114 mg [n = 6] for control rings of cromakalim and rings treated with glibenclamide; 100%= 840 +/− 215 mg [n = 5] and 800 +/− 198 mg [n = 5] for control rings of pinacidil and rings treated with glibenclamide, respectively). *Difference between control rings and rings treated with glibenclamide is statistically significant (P < 0.05).

Figure 1. Concentration-response curves to cromakalim (10-7to 3 x 10 (-5) M) and pinacidil (10-7to 3 x 10-5M) in the absence and the presence of glibenclamide (5 x 10-6M), obtained in rat thoracic aortas without endothelia. Data are shown as the mean +/− SD and expressed as percent of maximal relaxation induced by papaverine (3 x 10-4M; 100%= 753 +/− 169 mg [n = 6] and 887 +/− 114 mg [n = 6] for control rings of cromakalim and rings treated with glibenclamide; 100%= 840 +/− 215 mg [n = 5] and 800 +/− 198 mg [n = 5] for control rings of pinacidil and rings treated with glibenclamide, respectively). *Difference between control rings and rings treated with glibenclamide is statistically significant (P < 0.05).

Close Modal

or Create an Account

Close Modal
Close Modal